Biosimilars and Interchangeable Biologics: Strategic Elements
Hardcover
$200.00
(
$400.00
)Save 50%In stock
This item is currently out of stock online.
Not Eligible for Free ShippingSelect a store to view item availability.
What’s the Deal with Biosimilars?
Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development.
Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of b...






















